NOTIFICATION OF TRADE AMONG PRIMARY INSIDERS

On 16 November 2009 mandatory notifications of trade among primary insiders of DiaGenic ASA took place. The primary insiders have settled forward contracts by purchasing 1,245,000 shares. In addition the primary insiders have entered into Total Return equity Swap (TRS) agreements with exposure for 835,000 shares in DiaGenic. Net exposure among the insiders is unchanged by these transactions. The transactions are described in more detail below. CEO Erik Christensen has today settled a forward contract for the purchase of 50,000 shares in DiaGenic at NOK 2.71 per share. Christensen owns a total of 150,000 shares after the transaction. Håkon Sæterøy, Executive Chairman of the Board of DiaGenic ASA, has today settled two forward contracts for the purchase of 135,000 shares at NOK 3.22 per share and 100,000 shares at NOK 2.71 per share. Investor Corporate AS, which is controlled by Sæterøy, has subsequently entered into a Total Return equity Swap agreement (TRS) with exposure of 135,000 underlying shares. Expiry date is 26 January 2010, and the TRS price is NOK 3.24 per share. After these transactions, Sæterøy directly and indirectly owns a total of 1,241,478 shares in addition to the TRS agreement with exposure for 135,000 shares. Director and board member Praveen Sharma has today settled two forward contracts for the purchase of 260,000 shares at NOK 2.71 per share, and 700,000 shares at NOK 3.06 per share. Sharma has subsequently entered into a Total Return equity Swap agreement (TRS) with exposure of 700,000 underlying shares. Expiry date is 16 January 2010, and the TRS price is NOK 3.08 per share. After the transactions Sharma owns a total of 2,295,000 shares in DiaGenic in addition to the TRS agreement with exposure for 700,000 shares. This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act). Contact: MD PhD Erik Christensen, Managing Director Telephone: +47 95939918 e-mail: erik.christensen@diagenic.com